ThermoGenesis Holdings, Inc. (THMO) Stock Price & Analysis

ThermoGenesis Holdings, Inc. (THMO) closed at USD 0 on Wednesday, October 14, 2026, up 0.00% on the day. The US market is currently closed; this is not a live price.

The prior close was USD 0; the Oct 14, 2026 session ranged USD 0–0 on volume of 100 shares. Market capitalization is $1,584, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, retrieved October 16, 2026 at 06:43 UTC.

Also available as compact Markdown for AI agents: nexqual.com/THMO.md

Key facts (THMO)

Analysts (THMO)

Consensus None.

Total return (dividends reinvested) (THMO)

1Y (from 2025-10-16)5Y (from 2021-10-11)
Total return+0.0%-100.0%
S&P 500 (SPY)+18.1%+85.1%
Per year+0.0%-93.4%
Volatility (annualized)0.0%359.5%
Max drawdown+0.0% (→)-100.0% (Oct 2021→Apr 2025)

Key Statistics (as of October 16, 2026 at 06:43 UTC)

PriceUSD 0
Change▲ 0.00% (up)
Previous CloseUSD 0
OpenUSD 0
Day RangeUSD 0 – 0
52-Week RangeUSD 0 – 0
Volume100 shares
Market Cap$1,584
ExchangePNK

Technical Analysis (THMO)

Nexqual's technical model rates THMO "STRONG SELL" based on 0 bullish and 5 bearish signals across 126 daily candles, as of October 16, 2026 at 06:43 UTC.

Overall SignalSTRONG SELL
RSI (14)100 (overbought)
vs SMA50Below (USD 0)
MACD0 (negative)

Analyst Ratings (THMO)

Wall Street analysts rate THMO "None", per Nexqual as of October 16, 2026 at 06:43 UTC.

Consensus RatingNone

Earnings (THMO)

Recent Earnings History

QuarterActual vs Estimate
2024-03-31USD -0.46 vs est 0.01 ▼ miss
2023-12-31USD -1.65 vs est -0.01 ▼ miss
2023-09-30USD -1.44 vs est -0.21 ▼ miss
2023-06-30USD -0.91 vs est 0.01 ▼ miss

Source: Nexqual, October 16, 2026 at 06:43 UTC.

Financials & Fundamentals (THMO)

Total Revenue$9.61M
Revenue Growth (latest quarter, YoY)+6.40%
Gross Margin+21.10%
Operating Margin-20.35%
Profit Margin-153.43%
ROE-801.94%
Current Ratio0.52
Total Cash$1.18M
Total Debt$7.57M

Source: Nexqual, October 16, 2026 at 06:43 UTC.

Financial Health Score (THMO)

Nexqual rates ThermoGenesis Holdings, Inc.'s overall financial health "Weak" across five dimensions, as of October 16, 2026 at 06:43 UTC.

GrowthWeak — Revenue -10% YoY (annual), declining
ProfitabilityWeak — Not yet profitable — scaling phase
Balance SheetMixed — $1M cash vs $8M debt
Cash FlowWeak — Operating cash flow -$4M (TTM)
EfficiencyCritical — ROE -802%, ROA -25.5%

Ownership (THMO)

Insider Ownership+0.00%
Institutional Ownership+0.00%
Shares Outstanding15.85M
Float1.76M
Short % of Float+0.97%

Source: Nexqual, October 16, 2026 at 06:43 UTC.

Leadership (THMO)

ThermoGenesis Holdings, Inc. is led by Xiaochun Xu (age 54), Chairman of the Board & CEO, per Nexqual as of October 16, 2026 at 06:43 UTC.

Chairman of the Board & CEOXiaochun Xu (age 54)
Chief Operating OfficerHaihong Zhu (age 59)

Major Backers & Investors (THMO)

Index Funds (Passive)

FundStake
Vanguard Group0.45%

Source: Nexqual, October 16, 2026 at 06:43 UTC.

Peers & Related Stocks

SymbolNamePriceChange
ESTAEstablishment Labs Holdings IncUSD 61.36▲ 4.98%
ALMRAlamar Biosciences, Inc.USD 27.42▲ 16.58%
INSPInspire Medical Systems, Inc.USD 70.12▲ 1.83%
BFLYButterfly Network, Inc.USD 7.85▼ 3.09%
AXGNAxoGen, Inc.USD 35.63▼ 1.49%
UFPTUFP Technologies, Inc.USD 297.19▲ 0.99%

Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 06:43 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt